循环瘤细胞数量的纵向分析改善了对转移性乳腺癌进展的跟踪
Malgorzata Szostakowska-Rodzos1, Anna Fabisiewicz1, Maciej Wakula1
1Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Scientific reports
|June 5, 2024
概括
在转移性乳腺癌 (mBC) 中监测循环瘤细胞 (CTC) 提供预后价值. 随着时间的推移跟踪CTC动态和遗传变化,为疾病进展和治疗耐药性提供了关键的见解.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 激素反应性乳腺癌很常见,但远程转移显著降低了生存率.
- 监测转移性乳腺癌 (mBC) 进展对于患者管理至关重要.
- 循环瘤细胞 (CTC) 显示出诊断潜力,但缺乏确定的预后价值.
研究的目的:
- 评估循环瘤细胞 (CTC) 数量及其在晚期乳腺癌中的动态的预后价值.
- 与初级瘤相比,评估CTCs中的分子变化,重点关注与内分泌治疗耐药性相关的基因.
- 确定CTC遗传分析是否可以追踪耐药性并指导治疗决策.
主要方法:
- 对135名转移性乳腺癌患者进行了长度研究,并进行了三次连续血液采集.
- 使用EpCAM独立的CytoTrack系统检测和隔离循环瘤细胞 (CTC).
- 用下一代测序 (NGS) 分析单独的CTC用于突变分析.
主要成果:
- CTC状态对无进展和整体存活具有重要意义.
- 对CTC动态的纵向监测在预测临床进展方面比单次计数提供了优势.
- 在CTC中,高遗传和表型异质性表明异异的转移性病变和潜在的早期传播.
结论:
- 持续监测CTC及其动态对于管理晚期乳腺癌至关重要.
- 观察到的CTC异质性凸显了转移性疾病的复杂性.
- 这项研究没有证实CTC激活突变的趋势,导致抗雌激素耐药性.
更多相关视频
14:14Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
15.9K
05:23Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
Published on: July 7, 2023
1.0K
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
